Concepedia

Nitin Mehrotra

NM

32

Publications

2.2K

Citations

22

H-Index

1991

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Merck & Co., Inc., Rahway, NJ, USA (United States)

Central Drug Research Institute

University of Tennessee Health Science Center

Nitin Mehrotra is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacology, and pharmacotherapy.

Top concepts

MedicinePharmacologyPharmacotherapyOncologyDrug DiscoveryBiologyGeneticsDrug SafetyEpidemiologyDrug Analysis

Publications per year

1991–2022

32

Publications

32

FDA Approval: Blinatumomab

Donna Przepiorka, Chia‐Wen Ko, Albert Deisseroth et al. · Clinical Cancer Research · 2015 · 347 citations

FDA Approval: Ado-Trastuzumab Emtansine for the Treatment of Patients with HER2-Positive Metastatic Breast Cancer

Laleh Amiri‐Kordestani, Gideon M. Blumenthal, Qiang Xu et al. · Clinical Cancer Research · 2014 · 336 citations

Metastatic Breast Cancer, Independent Review Committee, Breast Oncology +13

A large waterborne viral hepatitis E epidemic in Kanpur, India

S. R. Naik, Rakesh Aggarwal, Pooja Salunke et al. · The Indian Journal of Pediatrics · 1993 · 263 citations

Virus Epidemiology, Viral Hepatitis, Hepatitis +5

Impact of Pharmacometric Analyses on New Drug Approval and Labelling Decisions

Joo Yeon Lee, Christine Garnett, Jogarao Gobburu et al. · Clinical Pharmacokinetics · 2011 · 146 citations

Drug Safety, Labelling Decisions, New Drug Approval +9

Hepatitis E virus genome in stools of hepatitis patients during large epidemic in north India

Ranjit Ray, G. P. Talwar, Rakesh Aggarwal et al. · The Lancet · 1991 · 101 citations

Hepatic Disorders, Hepatitis Patients, North India +7

Rows per page

1–5 of 32